Pediatric Lta Kit

   
Google
 
Web NewDrugInformation.com

Pediatric Lta Kit


Drug - Pediatric Lta Kit
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lidocaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 2%
The potency of the active ingredient(s), Lidocaine Hydrochloride. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Pediatric Lta Kit. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 085995
The FDA assigned number to Pediatric Lta Kit. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Pediatric Lta Kit. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Pediatric Lta Kit was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Pediatric Lta Kit. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Pediatric Lta Kit is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Pediatric Lta Kit.

Pediatric Lta Kit